JP Morgan Chase
VRAX icon

JP Morgan Chase’s Virax Biolabs VRAX Stock Holding History

JP Morgan Chase’s Portfolio VRAX Stock Details VRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4 Buy
+2
New +$6 ﹤0.01% 8136

Other funds holding VRAX

Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

JP Morgan Chase's VRAX Position: Q3 2026 in Review

JP Morgan Chase opened a new position in Virax Biolabs (VRAX) in Q3 2026: 2 shares worth $4. The stake represents ﹤0.01% of the portfolio and ranks #8136 among its holdings.

4 funds tracked by Wall St. Rank hold VRAX as of Q3 2026.

  • JP Morgan Chase held 2 shares of Virax Biolabs worth $4 as of Q3 2026.
  • Virax Biolabs was a new JP Morgan Chase position in Q3 2026.
  • Virax Biolabs made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #8136 holding.
  • 4 funds tracked by Wall St. Rank held Virax Biolabs as of Q3 2026.

Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.